Education
About Us
Working with TipRanks
Follow Us
Bolt Biotherapeutics (DE:6LP)
FRANKFURT:6LP
RESEARCH TOOLSreports
Bolt Biotherapeutics (6LP) Ownership Overview
11.12%
Insiders
3.84%
Mutual Funds
41.22% Other Institutional Investors
3.21% ETFs
40.61% Public Companies and
Individual Investors
The ownership structure of Bolt Biotherapeutics (DE:6LP) stock is a mix of institutional, retail, and individual investors. Approximately 48.27% of the company’s stock is owned by Institutional Investors, 11.12% is owned by Insiders, and 40.61% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,754,437 | Insider | 7.18% | 809,804 | |
| 1,448,286 | Insider | 3.78% | 425,796 | |
| 1,169,705 | Institution | 3.05% | 343,893 | |
| 1,067,405 | Institution | 2.78% | 313,817 | |
| 292,388 | Institution | 0.76% | 85,962 | |
| 62,899 | Institution | 0.16% | 18,492 | |
| 60,200 | Institution | 0.16% | 17,699 | |
| 50,695 | Institution | 0.13% | 14,904 | |
| 41,272 | Insider | 0.11% | 12,134 | |
| 16,633 | Insider | 0.04% | 4,890 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,067,405 | Institution | 2.78% | 313,817 | |
| 292,388 | Institution | 0.76% | 85,962 | |
| 60,200 | Institution | 0.16% | 17,699 | |
| 50,695 | Institution | 0.13% | 14,904 | |
| 2,700 | Institution | <0.01% | 794 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Bolt Biotherapeutics (DE:6LP)?
According to the latest TipRanks data, approximately 41.22% of the company's stock is held by institutional investors, 11.12% is held by insiders, and 40.61% is held by retail investors.
What percentage of Bolt Biotherapeutics (DE:6LP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 41.22% of Bolt Biotherapeutics (DE:6LP) stock is held by institutional investors.
What percentage of Bolt Biotherapeutics (DE:6LP) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.61% of Bolt Biotherapeutics (DE:6LP) stock is held by retail investors.
Who owns the most shares of Bolt Biotherapeutics (DE:6LP)?
James Healy owns the most shares of Bolt Biotherapeutics (DE:6LP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.